Tandem Diabetes Care (TNDM) Inventory (2013 - 2026)

Tandem Diabetes Care (TNDM) has reported Inventory for 14 consecutive years, with $135.1 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Inventory fell 5.24% year-over-year to $135.1 million; the trailing twelve-month figure through Jun 2026 stood at $135.1 million (down 5.24% YoY), and the FY2025 full-year result was $128.8 million, down 13.93% from the prior year.
• Inventory grew to $135.1 million in Q2 2026 per TNDM's latest filing, from $126.4 million in the prior quarter.
• Across five years, Inventory topped out at $161.7 million in Q2 2024 and bottomed at $80.0 million in Q1 2022.
• Historically, Inventory has averaged $133.0 million across 5 years, with a median of $139.2 million in 2025.
• The sharpest annual moves came in 2023 and 2025: Inventory surged 67.54% in 2023, then slipped 13.93% in 2025.
• Over 5 years, Inventory stood at $111.1 million in 2022, then surged by 42.14% to $157.9 million in 2023, then declined by 5.27% to $149.6 million in 2024, then dropped by 13.93% to $128.8 million in 2025, then gained by 4.92% to $135.1 million in 2026.
• According to Business Quant data, Inventory over the past three periods registered $135.1 million, $126.4 million, and $128.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.